Myasthenia gravis: A review of available treatment approaches

Autoimmune Diseases

Volumn 1, Issue 1, 2011, Pages

  Gilhus, Nils Erik ^a,b   Owe, Jone F ^a,b   Hoff, Jana Midelfart ^a,b   Romi, Fredrik ^a,b   Skeie, Geir Olve ^a,b   Aarli, Johan A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; MUSCLE SPECIFIC KINASE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG CHOICE; DRUG MEGADOSE; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VACCINATION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MATERNAL AGE; MORNING DOSAGE; MYASTHENIA GRAVIS; ONSET AGE; OPTIMAL DRUG DOSE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; THYMECTOMY; THYMOMA; TRAINING; UNSPECIFIED SIDE EFFECT; WEIGHT CONTROL;

EID: 84860774210     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.4061/2011/847393     Document Type: Review

References (32)

1. Andersen J. B., Engeland A., Owe J. F., Gilhus N. E., Myasthenia gravis requiring pyridostigmine treatment in a national population cohort European Journal of Neurology 2010 17 12 1445 1450
2. Owe J. F., Daltveit A. K., Gilhus N. E., Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001 Journal of Neurology, Neurosurgery Psychiatry 2006 77 2 203 207 (Pubitemid 43220844)
3. Gilhus N. E., Autoimmune myasthenia gravis Expert Review of Neurotherapeutics 2009 9 3 351 358
4. Leite M. I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B. P., Beeson D., Willcox N., Vincent A., IgG1 antibodies to acetylcholine receptors in seronegative myasthenia gravis Brain 2008 131 7 1940 1952 (Pubitemid 351957451)
5. Leite M. I., Waters P., Vincent A., Diagnostic use of autoantibodies in myasthenia gravis Autoimmunity 2010 43 5-6 371 379
6. Jaretzki A. III, Barohn R. J., Ernstoff R. M., Kaminski H. J., Keesey J. C., Penn A. S., Sanders D. B., Myasthenia gravis: recommendations for clinical research standards Neurology 2000 55 1 16 23 (Pubitemid 30460991)
7. Evoli A., Acquired myasthenia gravis in childhood Current Opinion in Neurology 2010 23 5 536 540
8. Hoff J. M., Daltveit A. K., Gilhus N. E., Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care European Journal of Neurology 2007 14 1 38 43 (Pubitemid 46088034)
9. McGrogan A., Sneddon S., De Vries C. S., The incidence of myasthenia gravis: a systematic literature review Neuroepidemiology 2010 34 3 171 183
10. Skeie G. O., Apostolski S., Evoli A., Gilhus N. E., Illa I., Harms L., Hilton-Jones D., Melms A., Verschuuren J., Horge H. W., Guidelines for treatment of autoimmune neuromuscular transmission disorders European Journal of Neurology 2010 17 7 893 902
11. Gilhus N. E., Acute treatment for myasthenia gravis Nature Reviews Neurology 2011 7 3 132 134
12. Elovaara I., Apostolski S., van Doorn P., Gilhus N. E., Hietaharju A., Honkaniemi J., van Schaik I. N., Scolding N., Soelberg Srensen P., Udd B., EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases European Journal of Neurology 2008 15 9 893 908
13. Gajdos P., Chevret S., Toyka K., Plasma exchange for myasthenia gravis and Intravenous immunoglobulin for myasthenia gravis The Cochrane Library 2009 1
14. Evoli A., Bianchi M. R., Riso R., Minicuci G. M., Batocchi A. P., Servidei S., Scuderi F., Bartoccioni E., Response to therapy in myasthenia gravis with anti-MuSK antibodies Annals of the New York Academy of Sciences 2008 1132 76 83 (Pubitemid 351841355)
15. Jani-Acsadi A., Lisak R. P., Myasthenia gravis Current Treatment Options in Neurology 2010 12 3 231 243
16. Kumar V., Kaminski H. J., Treatment of myasthenia gravis Current Neurology and Neuroscience Reports 2011 11 89 96
17. Conti-Fine B. M., Milani M., Kaminski H. J., Myasthenia gravis: past, present, and future Journal of Clinical Investigation 2006 116 11 2843 2854 (Pubitemid 44684466)
18. Sanders D. B., Evoli A., Immunosuppressive therapies in myasthenia gravis Autoimmunity 2010 43 5-6 428 435
19. Palace J., Newsom-Davis J., Lecky B., A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis Neurology 1998 50 6 1778 1783 (Pubitemid 28283251)
20. Sanders D. B., Siddiqi Z. A., Lessons from two trials of mycophenolate mofetil in myasthenia gravis Annals of the New York Academy of Sciences 2008 1132 249 253 (Pubitemid 351841371)
21. Tindall R. S. A., Phillips J. T., Rollins J. A., Wells L., Hall K., A clinical therapeutic trial of cyclosporine in myasthenia gravis Annals of the New York Academy of Sciences 1993 681 539 551 (Pubitemid 23233874)
22. Benveniste O., Hilton-Jones D., The role of rituximab in the treatment of myasthenia gravis European Neurology Review 2010 5 95 100
23. Minami N., Fujiki N., Doi S., Shima K., Niino M., Kikuchi S., Sasaki H., Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis Journal of the Neurological Sciences 2011 300 1-2 59 62
24. Kondo K., Optimal therapy for thymoma Journal of Medical Investigation 2008 55 1-2 17 28 (Pubitemid 351643589)
25. Gilhus N. E., Aarli J. A., Janzen R. W. C., Otto H. F., Fasske E., Matre R., Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis Journal of Neuroimmunology 1985 8 2-3 69 78 (Pubitemid 15070118)
26. Gronseth G. S., Barohn R. J., Thymectomy for autoimmune myasthenia gravis: an evidence-based review Neurology 2000 55 1 7 15
27. Mantegazza R., Baggi F., Bernasconi P., Antozzi C., Confalonieri P., Novellino L., Spinelli L., Ferr M. T., Beghi E., Cornelio F., Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients Journal of the Neurological Sciences 2003 212 1-2 31 36 (Pubitemid 36700397)
28. Hoff J. M., Daltveit A. K., Gilhus N. E., Myasthenia gravis: consequences for pregnancy, delivery, and the newborn Neurology 2003 61 10 1362 1366 (Pubitemid 37463371)
29. Polizzi A., Huson S. M., Vincent A., Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis Teratology 2000 62 5 332 341
30. Fostieri E., Kostelidou K., Poulas K., Tzartos S. J., Recent advances in the understanding and therapy of myasthenia gravis Future Neurology 2006 1 799 817
31. Lindstrom J., Luo J., Kuryatov A., Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains Annals of the New York Academy of Sciences 2008 1132 29 41 (Pubitemid 351841350)
32. Matsumoto Y., Matsuo H., Sakuma H., Park I. K., Tsukada Y., Kohyama K., Kondo T., Kotorii S., Shibuya N., CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis Journal of Immunology 2006 176 8 5100 5107